Scleraxis (SCX): A novel therapeutic target in the malignant transformation of oral potentially malignant disorders
Saved in:
Main Authors: | Bharathi Selvaraj, Dhanraj Ganapathy, Saravanan Sekaran |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024002152 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miR-1266-5p as a prognostic marker and miR-1255-5p/DAB2IP axis a therapeutic target in malignant transformation of oral submucous fibrosis
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01) -
Exploring FBXO43 as a potential therapeutic target: Implications for oral cancer progression
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01) -
Green tea epigallocatechin-3-gallate (EGCG): A promising therapeutic agent for oral cancer
by: Saravanan Sekaran, et al.
Published: (2024-03-01) -
Pyrotinib: A promising therapeutic prospect for treating metastatic salivary gland cancer
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01) -
Oral microbiota dysbiosis and its association with oral squamous cell carcinoma: Implications for early detection and preventive strategies
by: Bharathi Selvaraj, et al.
Published: (2024-06-01)